Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countriesGlobal social policy, 2018-04, Vol.18 (1), p.7-27 [Peer Reviewed Journal]The Author(s) 2017 ;ISSN: 1468-0181 ;EISSN: 1741-2803 ;DOI: 10.1177/1468018117734153Digital Resources/Online E-Resources |
2 |
Material Type: Book
|
![]() |
Canada and Access to Medicines in Developing Countries: Intellectual Property Rights FirstISBN1-77125-092-5Digital Resources/Online E-Resources |
3 |
Material Type: Article
|
![]() |
Canada and access to medicines in developing countries: intellectual property rights firstGlobalization and health, 2013-09, Vol.9 (1), p.42-42 [Peer Reviewed Journal]COPYRIGHT 2013 BioMed Central Ltd. ;Copyright © 2013 Lexchin; licensee BioMed Central Ltd. 2013 Lexchin; licensee BioMed Central Ltd. ;ISSN: 1744-8603 ;EISSN: 1744-8603 ;DOI: 10.1186/1744-8603-9-42 ;PMID: 24007595Full text available |
4 |
Material Type: Article
|
![]() |
DRUG ECONOMICS IN DEVELOPING COUNTRIESThe Lancet (British edition), 1989-09, Vol.334 (8664), p.678-678 [Peer Reviewed Journal]1989 ;Copyright Elsevier Limited Sep 16, 1989 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(89)90922-7 ;PMID: 2570925Full text available |
5 |
Material Type: Article
|
![]() |
Medicine donations: a review of policies and practicesGlobalization and health, 2023-09, Vol.19 (1), p.67-67, Article 67 [Peer Reviewed Journal]2023. BioMed Central Ltd., part of Springer Nature. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1744-8603 ;EISSN: 1744-8603 ;DOI: 10.1186/s12992-023-00964-3 ;PMID: 37658389Full text available |
6 |
Material Type: Article
|
![]() |
The pharmaceutical industry as a medicines providerThe Lancet (British edition), 2002-11, Vol.360 (9345), p.1590-1595 [Peer Reviewed Journal]2002 Elsevier Ltd ;2003 INIST-CNRS ;Copyright Lancet Ltd. Nov 16, 2002 ;Copyright Elsevier Limited Nov 16, 2002 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(02)11527-3 ;PMID: 12443614 ;CODEN: LANCAOFull text available |
7 |
Material Type: Article
|
![]() |
The Pharmaceutical Industry in Contemporary CapitalismMonthly review (New York. 1949), 2018-03, Vol.69 (10), p.37-50 [Peer Reviewed Journal]Copyright Monthly Review Press Mar 2018 ;ISSN: 0027-0520 ;EISSN: 0027-0520 ;DOI: 10.14452/MR-069-10-2018-03_3Full text available |
8 |
Material Type: Article
|
![]() |
Economics and industry do not mean ethical conduct in clinical trialsJournal of pharmaceutical policy and practice, 2013-12, Vol.6 (1), p.11-11, Article 11 [Peer Reviewed Journal]COPYRIGHT 2013 BioMed Central Ltd. ;Copyright © 2013 Lexchin; licensee BioMed Central Ltd. 2013 Lexchin; licensee BioMed Central Ltd. ;ISSN: 2052-3211 ;EISSN: 2052-3211 ;DOI: 10.1186/2052-3211-6-11 ;PMID: 25848540Full text available |
9 |
Material Type: Article
|
![]() |
Educating health professionals about drug and device promotion: a Nepalese perspectivePLoS medicine, 2007-02, Vol.4 (2), p.e89; author reply e88-e89; author reply e88 [Peer Reviewed Journal]COPYRIGHT 2007 Public Library of Science ;COPYRIGHT 2007 Public Library of Science ;2007 P. Ravi Shankar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Shankar PR (2007) Educating Health Professionals about Drug and Device Promotion: A Nepalese Perspective. PLoS Med 4(2): e89. doi:10.1371/journal.pmed.0040089 ;2007 P. Ravi Shankar. 2007 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.0040089 ;PMID: 17326721Full text available |
10 |
Material Type: Article
|
![]() |
Patent lawThe Lancet (British edition), 2003-03, Vol.361 (9362), p.1059-1059 [Peer Reviewed Journal]2003 Elsevier Ltd ;Copyright National Library of Medicine - MEDLINE Abstracts Mar 22 2003 ;Copyright Elsevier Limited Mar 22, 2003 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(03)12810-3 ;PMID: 12660088 ;CODEN: LANCAOFull text available |
11 |
Material Type: Article
|
![]() |
Intellectual property rights and drug pricesThe Lancet (British edition), 1998-08, Vol.352 (9127), p.582-582 [Peer Reviewed Journal]1998 Elsevier Ltd ;Copyright National Library of Medicine - MEDLINE Abstracts Aug 15 1998 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)79300-4 ;PMID: 9716098 ;CODEN: LANCAOFull text available |
12 |
Material Type: Article
|
![]() |
Pharmaceutical Promotion in the Third WorldJournal of drug issues, 1992-04, Vol.22 (2), p.417-453 [Peer Reviewed Journal]1992 Florida State University College of Criminology and Criminal Justice ;Copyright Florida State University for and on behalf of The Florida State University Board of Trustees Spring 1992 ;ISSN: 0022-0426 ;EISSN: 1945-1369 ;DOI: 10.1177/002204269202200218 ;CODEN: JDGIA6Full text available |
13 |
Material Type: Article
|
![]() |
One step forward, one step sideways? Expanding research capacity for neglected diseasesBMC international health and human rights, 2010-07, Vol.10 (1), p.20-20, Article 20 [Peer Reviewed Journal]COPYRIGHT 2010 BioMed Central Ltd. ;COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Lexchin; licensee BioMed Central Ltd. 2010 Lexchin; licensee BioMed Central Ltd. ;ISSN: 1472-698X ;EISSN: 1472-698X ;DOI: 10.1186/1472-698X-10-20 ;PMID: 20630063Full text available |
14 |
Material Type: Article
|
![]() |
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?Healthcare policy, 2023-02, Vol.18 (3), p.17-24 [Peer Reviewed Journal]Copyright © 2023 Longwoods Publishing ;Copyright Longwoods Publishing Corporation Feb 2023 ;Copyright © 2023 Longwoods Publishing 2023 Longwoods Publishing ;ISSN: 1715-6572 ;EISSN: 1715-6580 ;DOI: 10.12927/hcpol.2023.27038 ;PMID: 36917450Full text available |
15 |
Material Type: Article
|
![]() |
Myths and Realities About Why Prescription Drug Prices in the United States Are So HighPharmaceutical medicine, 2017-06, Vol.31 (3), p.143-148 [Peer Reviewed Journal]Springer International Publishing Switzerland 2017 ;Copyright Springer Science & Business Media Jun 2017 ;ISSN: 1178-2595 ;EISSN: 1179-1993 ;DOI: 10.1007/s40290-017-0191-9Full text available |
16 |
Material Type: Article
|
![]() |
Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviewsBMC health services research, 2013-03, Vol.13 (1), p.88-88, Article 88 [Peer Reviewed Journal]COPYRIGHT 2013 BioMed Central Ltd. ;2013 Bishop and Lexchin; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2013 Bishop and Lexchin; licensee BioMed Central Ltd. 2013 Bishop and Lexchin; licensee BioMed Central Ltd. ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/1472-6963-13-88 ;PMID: 23497271Full text available |
17 |
Material Type: Article
|
![]() |
Pharmaceutical research and development: what do we get for all that money?BMJ (Online), 2012-08, Vol.345 (aug07 1), p.e4348-e4348 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2012 ;Copyright: 2012 © BMJ Publishing Group Ltd 2012 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.e4348 ;PMID: 22872694Full text available |
18 |
Material Type: Article
|
![]() |
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort StudyInternational journal of health policy and management, 2021-08, Vol.10 (8), p.495-499 [Peer Reviewed Journal]2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;COPYRIGHT 2021 Kerman University of Medical Sciences ;2021 The Author(s); Published by Kerman University of Medical Sciences 2021 ;ISSN: 2322-5939 ;EISSN: 2322-5939 ;DOI: 10.34172/ijhpm.2020.100 ;PMID: 32610816Full text available |
19 |
Material Type: Article
|
![]() |
From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline developmentJournal of evaluation in clinical practice, 2014-12, Vol.20 (6), p.809-812 [Peer Reviewed Journal]2014 John Wiley & Sons, Ltd. ;ISSN: 1356-1294 ;EISSN: 1365-2753 ;DOI: 10.1111/jep.12244 ;PMID: 25327453Full text available |
20 |
Material Type: magazinearticle
|
![]() |
Crisis at the pharmacyCCPA monitor, 2018-03, Vol.24 (6), p.25Copyright Canadian Centre for Policy Alternatives Mar/Apr 2018 ;ISSN: 1198-497XFull text available |